全文获取类型
收费全文 | 3841篇 |
免费 | 225篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 175篇 |
妇产科学 | 57篇 |
基础医学 | 337篇 |
口腔科学 | 70篇 |
临床医学 | 435篇 |
内科学 | 687篇 |
皮肤病学 | 78篇 |
神经病学 | 230篇 |
特种医学 | 247篇 |
外科学 | 416篇 |
综合类 | 358篇 |
预防医学 | 362篇 |
眼科学 | 84篇 |
药学 | 312篇 |
3篇 | |
中国医学 | 100篇 |
肿瘤学 | 151篇 |
出版年
2023年 | 16篇 |
2022年 | 26篇 |
2021年 | 58篇 |
2020年 | 44篇 |
2019年 | 30篇 |
2018年 | 44篇 |
2017年 | 46篇 |
2016年 | 41篇 |
2015年 | 66篇 |
2014年 | 78篇 |
2013年 | 112篇 |
2012年 | 193篇 |
2011年 | 174篇 |
2010年 | 127篇 |
2009年 | 131篇 |
2008年 | 212篇 |
2007年 | 212篇 |
2006年 | 211篇 |
2005年 | 161篇 |
2004年 | 131篇 |
2003年 | 126篇 |
2002年 | 114篇 |
2001年 | 119篇 |
2000年 | 101篇 |
1999年 | 83篇 |
1998年 | 56篇 |
1997年 | 60篇 |
1996年 | 60篇 |
1995年 | 42篇 |
1994年 | 51篇 |
1993年 | 46篇 |
1992年 | 47篇 |
1991年 | 59篇 |
1990年 | 56篇 |
1989年 | 72篇 |
1988年 | 62篇 |
1987年 | 61篇 |
1986年 | 47篇 |
1985年 | 54篇 |
1984年 | 38篇 |
1983年 | 31篇 |
1980年 | 19篇 |
1975年 | 15篇 |
1969年 | 19篇 |
1959年 | 41篇 |
1958年 | 66篇 |
1957年 | 76篇 |
1956年 | 73篇 |
1955年 | 83篇 |
1954年 | 51篇 |
排序方式: 共有4124条查询结果,搜索用时 437 毫秒
61.
重组人胰高血糖素类多肽-1(7-36)对化学致糖尿病模型动物的降血糖作用 总被引:6,自引:0,他引:6
目的 本文研究了重组人胰高血糖素类多肽 1(7 36 )[rhGLP 1(7 36 ) ]对化学所致糖尿病模型动物的降血糖和促胰岛素分泌作用。方法 对四氧嘧啶型糖尿病小鼠及链脲霉素型糖尿病大鼠皮下注射不同剂量的rhGLP 1,分别于给药 4天后采血 ,收取血清 ,测定血糖及胰岛素值。结果 四氧嘧啶型糖尿病小鼠皮下注射 4 0、80 μg·kg-1rhGLP 1后 ,血糖值显著下降 (P <0 0 1) ,而 2 0 μg·kg-1剂量组则无显著性改变 ;链脲霉素型糖尿病大鼠皮下注射 2 8、5 6 μg·kg-1rhGLP 1后 ,血糖值显著下降 (P <0 0 5、P <0 0 1) ,而 14 μg·kg-1剂量组则无显著性改变。结论 rhGLP 1对实验动物部分 β细胞破坏的胰岛仍有促分泌胰岛素及降糖作用 相似文献
62.
目的 总结伴IKZF1基因缺失儿童急性淋巴细胞白血病(ALL)的临床特征并观察提高化疗强度对其预后的影响。方法 2015年12月至2018年2月间确诊并按照中国儿童白血病协作组-ALL 2008(CCLG-ALL 2008)方案规范治疗的ALL患儿共278例,根据有无IKZF1基因缺失将其分为IKZF1基因缺失组和IKZF1基因正常组,IKZF1基因缺失组均接受CCLG-ALL 2008高危(HR)方案治疗,IKZF1基因正常组则按临床危险度分型接受不同强度化疗,比较两组的临床特征及无事件生存(EFS)率。结果 278例患儿中共24例(8.6%)检出IKZF1基因外显子大片段缺失。IKZF1基因缺失组初诊时WBC ≥ 50×109/L、BCR-ABL1融合基因阳性、诱导缓解治疗第15天微小残留病≥ 10%、微小残留病-HR、临床危险度-HR所占比例均高于IKZF1基因正常组(P < 0.05)。IKZF1基因缺失组3年EFS率(76%±10%)低于IKZF1基因正常组(84%±4%),但差异无统计学意义(P=0.282);其中,IKZF1基因缺失组-非HR(实际按CCLG-ALL 2008 HR方案化疗)的预计3年EFS率为82%±12%,低于IKZF1基因正常组-非HR(86%±5%),但差异无统计学意义(P=0.436)。结论 伴IKZF1基因缺失的儿童ALL早期治疗反应更差,提高化疗强度可能改善其预后。 相似文献
63.
Dr Jeffrey S. Markowitz MPH Dr Elane M. Gutterman PhD Dr Bruce Link PhD Dr Maria Rivera 《Behavioral medicine (Washington, D.C.)》2013,39(2):84-93
Abstract Samples of firefighter subjects (n = 80) and a comparison group (n = 15) were contrasted on a number of postincident psychological distress measures in the aftermath of a polyvinyl chloride (PVC) fire. Using a structured, self-administered questionnaire, firefighter subjects were found to be more psychologically distressed on demoralization, specific emotional distress, and perceived threat to physical health. After controlling for baseline characteristics on which subjects and the comparison group differed, these between-group effects remained significant. The three outcome scales, while correlated, measure different components of psychological distress. 相似文献
64.
65.
Satoru Kudose Dominick Santoriello Hanna Debiec Pietro A. Canetta Andrew S. Bomback M. Barry Stokes Ibrahim Batal Pierre Ronco Vivette D. D’Agati Glen S. Markowitz 《Kidney international》2021,99(1):247-255
- Download : Download high-res image (415KB)
- Download : Download full-size image
66.
67.
68.
Lisa K. Ryan Katie B. Freeman Jorge A. Masso-Silva Klaudia Falkovsky Ashwag Aloyouny Kenneth Markowitz Amy G. Hise Mahnaz Fatahzadeh Richard W. Scott Gill Diamond 《Antimicrobial agents and chemotherapy》2014,58(7):3820-3827
There is a strong need for new broadly active antifungal agents for the treatment of oral candidiasis that not only are active against many species of Candida, including drug-resistant strains, but also evade microbial countermeasures which may lead to resistance. Host defense peptides (HDPs) can provide a foundation for the development of such agents. Toward this end, we have developed fully synthetic, small-molecule, nonpeptide mimetics of the HDPs that improve safety and other pharmaceutical properties. Here we describe the identification of several HDP mimetics that are broadly active against C. albicans and other species of Candida, rapidly fungicidal, and active against yeast and hyphal cultures and that exhibit low cytotoxicity for mammalian cells. Importantly, specificity for Candida over commensal bacteria was also evident, thereby minimizing potential damage to the endogenous microbiome which otherwise could favor fungal overgrowth. Three compounds were tested as topical agents in two different mouse models of oral candidiasis and were found to be highly active. Following single-dose administrations, total Candida burdens in tongues of infected animals were reduced up to three logs. These studies highlight the potential of HDP mimetics as a new tool in the antifungal arsenal for the treatment of oral candidiasis. 相似文献
69.
70.
M. RIGHINI G. LE GAL D. AUJESKY P.‐M. ROY O. SANCHEZ F. VERSCHUREN O. T. RUTSCHMANN T. PERNEGER A. PERRIER 《Journal of thrombosis and haemostasis》2012,10(3):347-351
Summary. Background: A pulmonary embolism (PE) is thought to be associated with atrial fibrillation (AF). Nevertheless, this association is based on weak data. Objectives: To assess whether the presence of AF influences the clinical probability of PE in a cohort of patients with suspected PE and to confirm the association between PE and AF. Patients/methods: We retrospectively analyzed the data from two trials that included 2449 consecutive patients admitted for a clinically suspected PE. An electrocardiography (ECG) was systematically performed and a PE was diagnosed by computer tomography (CT). The prevalence of AF among patients with or without a PE was compared in a multivariate logistic regression model. Results: The prevalence of PE was 22.8% (519/2272) in patients without AF and 18.8% (25/133) in patients with AF (P = 0.28). After adjustment for confounding factors, AF did not significantly modify the probability of PE (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.42–1.11). However, when PE suspicion was based on new‐onset dyspnea, AF significantly decreased the probability of PE (OR 0.47, 95% CI 0.26–0.84). If isolated chest pain without dyspnea was the presenting complaint, AF tended to increase the probability of PE (OR 2.42, 95% CI 0.97–6.07). Conclusions: Overall, the presence of AF does not increase the probability of PE when this diagnosis is suspected. Nevertheless, when PE suspicion is based on new‐onset dyspnea, AF significantly decreases the probability of PE, as AF may mimic its clinical presentation. However, in patients with chest pain alone, AF tends to increase PE probability. 相似文献